Drug makers get a preview of how US health regulators will judge new factory tech

The US health regulators released draft advice for drug companies. This advice explains how to meet existing quality rules when using new manufacturing technologies.

This document is the US health regulators' way of signaling how they will approach new drug manufacturing methods. It gives drug companies a chance to understand the agency's thinking and provide feedback before any rules become final. This helps companies plan investments in advanced factories without guessing what regulators will allow.